Oropharynx (OPX) Biomarker Trial
Oropharynx (OPX) Biomarker Trial
Recruiting · NCT06356272 · Registry updated 2026-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oropharynx (OPX) Biomarker Trial | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, endocrine system disorder, epithelial neoplasm, head and neck carcinoma, head and neck squamous cell carcinoma, malignant endocrine neoplasm, mouth disorder, neoplasm, oropharynx squamous cell carcinoma, otorhinolaryngologic disease, salivary gland cancer, salivary gland disorder, squamous cell carcinoma, thyroid gland disorder, thyroid tumor | Recruiting | Not stated | 2026-04-22 | NCT06356272 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | United States | 687 |